The Research and Development team at Clene Nanomedicine is dedicated to advancing innovative therapeutics for neurodegenerative diseases. Led by expert professionals, including the Head of Medical and Chief Science Officer, the team conducts cutting-edge research, develops micro and biological solutions, and engineers novel drug formulations to enhance patient outcomes and drive clinical success.
View all